OPENDEL Trademark

Trademark Overview


On Wednesday, April 19, 2023, a trademark application was filed for OPENDEL with the United States Patent and Trademark Office. The USPTO has given the OPENDEL trademark a serial number of 79374942. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by HitGen Inc.. The OPENDEL trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Chemico-pharmaceutical preparations for the treatment of diseases caused by bacteria; drugs for medical purposes, namely, pharmaceutical preparations for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, epstein-barr (eb) viruses, hormonal diseases, allergic, immune disorder, torch infections and immunoglobulin diseases; antibiotics; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases ...

Chemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; buffer solutions for use in analytical chemistry; biochemical catalysts

Technological research in the field of medical and healthcare; conducting technical project studies for determining the feasibility of new technologies; research and development of new products for others; scientific laboratory services; product quality evaluation; quality evaluation services for the medical and anesthesia industries; chemical research; chemistry consultation; chemical analysis; bacteriological research; biological research
opendel

General Information


Serial Number79374942
Word MarkOPENDEL
Filing DateWednesday, April 19, 2023
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7376720
Registration DateTuesday, May 7, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and ServicesChemico-pharmaceutical preparations for the treatment of diseases caused by bacteria; drugs for medical purposes, namely, pharmaceutical preparations for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, epstein-barr (eb) viruses, hormonal diseases, allergic, immune disorder, torch infections and immunoglobulin diseases; antibiotics; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines made of chinese traditional medicinal herbs; biochemical drugs for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, inflammatory disorders, dermatological conditions, oncological diseases, blood diseases, connective tissue disorders, ophthalmic diseases, and gastroenterological disorders; lotions for pharmaceutical purposes being medicated lotions for treating dermatological conditions; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; allergy tablets; antibiotic tablets; vitamin tablets; effervescent vitamin tablets
Goods and ServicesChemical preparations for scientific purposes, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; buffer solutions for use in analytical chemistry; biochemical catalysts
Goods and ServicesTechnological research in the field of medical and healthcare; conducting technical project studies for determining the feasibility of new technologies; research and development of new products for others; scientific laboratory services; product quality evaluation; quality evaluation services for the medical and anesthesia industries; chemical research; chemistry consultation; chemical analysis; bacteriological research; biological research

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, August 4, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 4, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHitGen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameHitGen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameHitGen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Thursday, July 20, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 3, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, August 8, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, January 17, 2024ASSIGNED TO EXAMINER
Wednesday, February 14, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 14, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2024NOTICE OF PUBLICATION
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024NOTIFICATION PROCESSED BY IB
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB